Measurement scales
| Measurement | ||
|---|---|---|
| scales | Median | SD |
| Organizational learning capacity (Lee and Song, 2015, p. 235; Yang, 2016, p. 307) | ||
| Cronbach's α = 0.891, AVE = 0.54, CR = 0.87 | ||
| How strongly do you agree with the following statement(s) about your firm's | ||
| Overall learning? My firm … | ||
| LRC1 … values new knowledge | 1.0 | 0.808 |
| LRC2 … distributes knowledge to all employees | 2.0 | 1.059 |
| LRC3 … trains employees effectively | 2.0 | 1.039 |
| LRC4 … values teamwork | 1.0 | 0.731 |
| LRC5 … values cross-functional cooperation | 1.0 | 0.850 |
| LRC6 … has a shared vision of purpose among its employees | 2.0 | 1.13 |
| Collaboration (Shou et al., 2017, p. 871; Yang and Lirn, 2017, p. 904) | ||
| Cronbach's α = 0.832, AVE = 0.47, CR = 0.78 | ||
| How strongly do you agree with the following statement(s) about your firm's overall inter-firm relations? My firm … | ||
| COLL1 … values communication with business partners | 1.0 | 0.757 |
| COLL2 … shares information with business partners | 2.0 | 0.840 |
| COLL3 … views business partners as an extension of the firm | 2.0 | 0.935 |
| COLL4 … values long-term relationships with business partners | 1.0 | 0.718 |
| Coopetition (Doz and Shuen, 1988; Fawcett et al., 2011; Mody, 1993; Teece et al., 1997) | ||
| Cronbach's α = 0.933, AVE = 0.81, CR = 0.93 | ||
| COOP1 … collaborates with rivals | 3.0 | 1.146 |
| COOP2 … learns from collaboration with rivals | 3.0 | 1.235 |
| COOP3 … values collaborating with rivals | 3.0 | 1.207 |
| Innovation (Lee and Song, 2015 p. 235; Shou et al., 2017, p. 871; Yang, 2016, p. 307) | ||
| Cronbach's α = 0.923 AVE = 0.84, CR = 0.84 | ||
| How strongly do you agree with the following statements about your firm's overall innovativeness? My firm … | ||
| INN1 … adopts new skills and technology | 2.0 | 1.085 |
| INN2 … introduces new products or services | 2.0 | 1.070 |
| INN3 … incorporates information about our industry, customers and competitors | 2.0 | 1.022 |
| INN4 … seeks creative solutions | 1.0 | 1.004 |
| INN5 … seeks new ideas and opportunities | 1.0 | 0.911 |
| Robustness (Brandon-Jones et al., 2014, p. 64; Essuman et al., 2020, p. 6; Wieland and Wallenburg, 2012, p. 904) | ||
| Cronbach's α = 0.873, AVE = 0.49, CR = 0.82 | ||
| How strongly do you agree with the following statements about your firm's robustness during COVID-19? In comparison to its competitors, my firm… | ||
| RBT1 … gave its employees enough time to consider a response | 2.0 | 0.977 |
| RBT2 … carried out its normal functions despite some damage | 2.0 | 0.986 |
| RBT3 … met operational needs despite some deviation | 2.0 | 0.969 |
| RBT4 … performed well over a variety of scenarios despite some adaptations | 2.0 | 0.912 |
| RBT5 … reduced the impacts of the pandemic by responding effectively | 2.0 | 1.035 |
| Dynamic recovery (Essuman et al., 2020, p. 6; Ponomarov and Holcomb, 2009; Tukamuhabwa et al., 2015) | ||
| Cronbach's α = 0.863, AVE = 0.49, CR = 0.82 | ||
| How strongly do you agree with the following statement(s) about your firm's recoverability since COVID-19? In comparison to its competitors, my firm… | ||
| SREC1 … recovered to normal operations successfully | 2.0 | 0.941 |
| SREC2 … recovered to normal operations quickly | 2.0 | 1.085 |
| SREC3 … recovered to normal operations easily | 2.0 | 1.114 |
| DREC1 … has developed new skills and capabilities | 2.0 | 1.009 |
| DREC2 … has improved its market position | 2.0 | 1.118 |
| LSQ (Rahman, 2006, p. 235) | ||
| Cronbach's α = 0.870, AVE = 0.5, CR = 0.83 | ||
| How strongly do you agree with the following statements about your firm's LSQ since COVID-19? My firm … | ||
| LSQ1 … has provided on-time delivery | 2.0 | 1.069 |
| LSQ2 … has provided undamaged goods upon delivery | 1.0 | 0.974 |
| LSQ3 … has provided error free transactions | 2.0 | 0.952 |
| LSQ4 … has provided consistent order cycles | 2.0 | 0.910 |
| LSQ5 … has provided total support of customer needs | 2.0 | 0.923 |
| Performance (Tseng and Liao, 2015, p. 93; Shou et al., 2017, p. 871) | ||
| How strongly do you agree with the following statements about your firm's performance since COVID-19? In comparison to its competitors, my firm … | ||
| Cronbach's α = 0.890, AVE = 0.39, CR = 0.75 | ||
| PERF1 … has superior customer satisfaction | 2.0 | 1.024 |
| PERF2 … has superior customer loyalty | 2.0 | 0.973 |
| PERF3 … has a superior reputation | 2.0 | 0.823 |
| PERF4 … has superior market share growth | 2.0 | 1.065 |
| PERF5 … has superior profitability | 2.0 | 1.114 |
| Measurement | ||
|---|---|---|
| scales | Median | SD |
| Cronbach's | ||
| How strongly do you agree with the following statement(s) about your firm's | ||
| Overall learning? My firm … | ||
| LRC1 … values new knowledge | 1.0 | 0.808 |
| LRC2 … distributes knowledge to all employees | 2.0 | 1.059 |
| LRC3 … trains employees effectively | 2.0 | 1.039 |
| LRC4 … values teamwork | 1.0 | 0.731 |
| LRC5 … values cross-functional cooperation | 1.0 | 0.850 |
| LRC6 … has a shared vision of purpose among its employees | 2.0 | 1.13 |
| Cronbach's | ||
| How strongly do you agree with the following statement(s) about your firm's overall inter-firm relations? My firm … | ||
| COLL1 … values communication with business partners | 1.0 | 0.757 |
| COLL2 … shares information with business partners | 2.0 | 0.840 |
| COLL3 … views business partners as an extension of the firm | 2.0 | 0.935 |
| COLL4 … values long-term relationships with business partners | 1.0 | 0.718 |
| Cronbach's | ||
| COOP1 … collaborates with rivals | 3.0 | 1.146 |
| COOP2 … learns from collaboration with rivals | 3.0 | 1.235 |
| COOP3 … values collaborating with rivals | 3.0 | 1.207 |
| Cronbach's | ||
| How strongly do you agree with the following statements about your firm's overall innovativeness? My firm … | ||
| INN1 … adopts new skills and technology | 2.0 | 1.085 |
| INN2 … introduces new products or services | 2.0 | 1.070 |
| INN3 … incorporates information about our industry, customers and competitors | 2.0 | 1.022 |
| INN4 … seeks creative solutions | 1.0 | 1.004 |
| INN5 … seeks new ideas and opportunities | 1.0 | 0.911 |
| Cronbach's | ||
| How strongly do you agree with the following statements about your firm's robustness during COVID-19? In comparison to its competitors, my firm… | ||
| RBT1 … gave its employees enough time to consider a response | 2.0 | 0.977 |
| RBT2 … carried out its normal functions despite some damage | 2.0 | 0.986 |
| RBT3 … met operational needs despite some deviation | 2.0 | 0.969 |
| RBT4 … performed well over a variety of scenarios despite some adaptations | 2.0 | 0.912 |
| RBT5 … reduced the impacts of the pandemic by responding effectively | 2.0 | 1.035 |
| Cronbach's | ||
| How strongly do you agree with the following statement(s) about your firm's recoverability since COVID-19? In comparison to its competitors, my firm… | ||
| SREC1 … recovered to normal operations successfully | 2.0 | 0.941 |
| SREC2 … recovered to normal operations quickly | 2.0 | 1.085 |
| SREC3 … recovered to normal operations easily | 2.0 | 1.114 |
| DREC1 … has developed new skills and capabilities | 2.0 | 1.009 |
| DREC2 … has improved its market position | 2.0 | 1.118 |
| Cronbach's | ||
| How strongly do you agree with the following statements about your firm's LSQ since COVID-19? My firm … | ||
| LSQ1 … has provided on-time delivery | 2.0 | 1.069 |
| LSQ2 … has provided undamaged goods upon delivery | 1.0 | 0.974 |
| LSQ3 … has provided error free transactions | 2.0 | 0.952 |
| LSQ4 … has provided consistent order cycles | 2.0 | 0.910 |
| LSQ5 … has provided total support of customer needs | 2.0 | 0.923 |
| How strongly do you agree with the following statements about your firm's performance since COVID-19? In comparison to its competitors, my firm … | ||
| Cronbach's | ||
| PERF1 … has superior customer satisfaction | 2.0 | 1.024 |
| PERF2 … has superior customer loyalty | 2.0 | 0.973 |
| PERF3 … has a superior reputation | 2.0 | 0.823 |
| PERF4 … has superior market share growth | 2.0 | 1.065 |
| PERF5 … has superior profitability | 2.0 | 1.114 |
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Please sign in to your personal account to gift article access.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses.
You have reached the limit of 10 links within a 30 day period.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.